Get Newsletter
Alzheimer Research Forum - Networking for a Cure Alzheimer Research Forum - Networking for a CureAlzheimer Research Forum - Networking for a Cure
  
What's New HomeContact UsHow to CiteGet NewsletterBecome a MemberLogin          
Papers of the Week
Current Papers
ARF Recommends
Milestone Papers
Search All Papers
Search Comments
News
Research News
Drug News
Conference News
Research
AD Hypotheses
  AlzSWAN
  Current Hypotheses
  Hypothesis Factory
Forums
  Live Discussions
  Virtual Conferences
  Interviews
Enabling Technologies
  Workshops
  Research Tools
Compendia
  AlzGene
  AlzRisk
  Antibodies
  Biomarkers
  Mutations
  Protocols
  Research Models
  Video Gallery
Resources
  Bulletin Boards
  Conference Calendar
  Grants
  Jobs
Early-Onset Familial AD
Overview
Diagnosis/Genetics
Research
News
Profiles
Clinics
Drug Development
Companies
Tutorial
Drugs in Clinical Trials
Disease Management
About Alzheimer's
  FAQs
Diagnosis
  Clinical Guidelines
  Tests
  Brain Banks
Treatment
  Drugs and Therapies
Caregiving
  Patient Care
  Support Directory
  AD Experiences
Community
Member Directory
Researcher Profiles
Institutes and Labs
About the Site
Mission
ARF Team
ARF Awards
Advisory Board
Sponsors
Partnerships
Fan Mail
Support Us
Return to Top
Home: News
News
News Search  
Assistant Gets the Glory: Lasker Award Goes to Chaperone Discovery
13 September 2011. The 2011 Albert Lasker Basic Medical Research Award, often viewed as a harbinger of the Nobel Prize, went to two scientists who established the role of molecular chaperones in protein folding—a process that, when it goes awry, plays a role in many neurodegenerative disorders, including Alzheimer’s disease (AD). Biochemist Franz-Ulrich Hartl, of the Max Planck Institute of Biochemistry in Martinsried, Germany, and biologist Arthur Horwich, of Yale University School of Medicine in New Haven, Connecticut, will receive the shared award at a ceremony on Friday, September 23, in New York City. “The contribution of molecular chaperones to a fundamental understanding of protein folding and misfolding has provided a common mechanism for the entire set of conformational diseases, with Alzheimer’s leading the way,” said Richard Morimoto of Northwestern University in Evanston, Illinois.

In the late 1980s, while conducting postgraduate work in the laboratory of biochemist Walter Neupert at the University of Munich, Germany, Hartl collaborated on a series of experiments with Horwich at Yale. Those studies led to the discovery that newly formed cellular proteins fold into their three-dimensional shapes within the barrel-shaped cavity of the so-called chaperonins Hsp60 and GroEL, which are a class of molecular chaperone. Subsequent studies by Hartl, Horwich, and others established details of the chaperone-assisted folding mechanism. At the same time, it became evident that assuming their correct three-dimensional shape not only allows proteins to perform their biological functions, but also prevents them from sticking to other proteins.

Protein misfolding and aggregation are involved in many diseases, including AD, Parkinson’s, Huntington’s, and amyotrophic lateral sclerosis (see ARF related news story on Sakahira et al., 2002 and Bonini, 2002 and ARF related news story on Kanekiyo et al., 2007 and Live Discussion). In recent years, several studies have implicated different molecular chaperones, many of which are heat-shock proteins, in neurodegenerative diseases, and found that chaperones' activity decreases with age (Morimoto, 2008). “As each of these diseases exhibits age-dependent effects, the challenge has been to understand how the heat-shock response and chaperone networks become compromised during aging, thus increasing the risk of misfolding diseases,” wrote Morimoto in an e-mail to ARF.—Laura Bonetta.

 
  Submit a Comment on this News Article
Cast your vote and/or make a comment on this news article. 

If you already are a member, please login.
Not sure if you are a member? Search our member database.

*First Name  
*Last Name  
Country or Territory:
*Login Email Address  
*Password    Minimum of 8 characters
*Confirm Password  
Stay signed in?  

Comment:

(If coauthors exist for this comment, please enter their names and email addresses at the end of the comment.)

References:


*Enter the verification code you see in the picture below:


This helps Alzforum prevent automated registrations.

Terms and Conditions of Use:Printable Version

By clicking on the 'I accept' below, you are agreeing to the Terms and Conditions of Use above.
Print this page
Email this page
Alzforum News
Papers of the Week
Text size
Share & Bookmark
ADNI Related Links
ADNI Data at LONI
ADNI Information
DIAN
Foundation for the NIH
AddNeuroMed
neuGRID
Desperately

Antibodies
Cell Lines
Collaborators
Papers
Research Participants
Copyright © 1996-2013 Alzheimer Research Forum Terms of Use How to Cite Privacy Policy Disclaimer Disclosure Copyright
wma logoadadad